Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD40 is a costimulatory receptor that plays a central role in immune regulation and homeostasis. It is a 48-kDa type I transmembrane protein belonging to the tumor necrosis factor receptor (TNFR) superfamily. The engagement between CD40 and its ligand (CD154/CD40L) triggers bidirectional signaling critical for both humoral and cellular immunity. Targeting the CD40–CD154 axis has therapeutic potential for cancer immunotherapy or modulation of autoimmune conditions.
Targeting the CD40–CD154 axis has therapeutic potential for cancer immunotherapy or modulation of autoimmune conditions
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD40 Costimulatory Receptor (CD40).